Vaibhav Srivastava

At Evimed, we provide consultancy services to the pharmaceutical industry, focussing on technical excellence in evidence synthesis, health economics and outcomes research, real world evidence, and pricing. Our streamlined solutions to enable patients faster access to innovative medicines. Our focus is on delivering fit-for-purpose, rapid, high quality, and practical analytical solutions to maximize outcomes, minimize delays, and ultimately enable faster access for patients. Our services include: - Literature reviews & evidence synthesis: systematic, targeted, or rapid literature reviews; indirect treatment comparisons, network meta-analysis, matching-adjusted indirect treatment comparisons, multi-level network meta-regression - Health economic modelling: cost-effectiveness models, technical and strategic model QC and validation, advisory support with economic models, budget impact models, cost per response models, cost consequence models, PVTO, and all other bespoke models - Localisation of SLR, NMA, and HE deliverables: we have extensive experience performing localisations in many geographies including UK, France, Canada, Nordics, and Portugal. - Statistical data analysis: generation of health economic inputs including quality of life / utility analyses, survival analysis, treatment switching, analysis of adverse events & discontinuation, healthcare resource use, cost and disutility, post-hoc analysis of clinical trials, bespoke tailored methodological approaches to support publications. - Health technology assessment: advise on HTA & submission strategy, evaluation of expected HTA & reimbursement outcomes, identification of risks and mitigation strategies, assessment of development programme in line with competitors and agency expectations, assessment of early pipeline assets, trade-off assessments for milestone and launch decisions, and evaluation of business development opportunities.